Effect of inhibition of nitric oxide synthase on chronic tension-type headache: A randomised crossover trial

Lancet

Volumn 353, Issue 9149, 1999, Pages 287-289

  Ashina, M ^a   Lassen, L H ^a   Bendtsen, L ^a   Jensen, R ^a   Olesen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; EXHAUSTION; FATIGUE; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; TIME; XEROSTOMIA;

EID: 0033026309     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)01079-4     Document Type: Article

References (29)

1. Ignarro LJ, Lippton H, Edwards JCet al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 218:1981;739-749.
2. Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:1991;109-141.
3. Garthwaite J Nitric oxide signalling in the nervous system. Neurosciences. 5:1993;171-180.
4. Haley JE, Dickenson AH, Schachter M Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
5. Meller ST, Gebhart GF Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
6. Meller ST, Cummings CP, Traub RJ, Gebhard GF The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
7. Minami T, Nishihara I, Ito Set al. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2 alpha in conscious mice. Pain. 61:1995;285-290.
8. Coderre TJ, Yashpal K Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neuroscience. 1:1994;1328-1334.
9. Hao J-X, Xu X-J Treatment of chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain. 6:1996;313-319.
10. Mao J, Price DD, Zhu J, Lu J, Mayer DJ The inhibition of nitric oxide-activated poly (ADP-ribose) synthase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain. 72:1997;355-366.
11. Rasmussen BK, Jensen R, Schroll M, Olesen J Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol. 44:1991;1147-1157.
12. Bendtsen L, Jensen R, Olesen J Qualitatively altered nociception in chronic myofascial pain. Pain. 65:1996;259-264.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (suppl 7): 1-96.
14. Russell MB, Rasmussen BK, Brennum Jet al. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 12:1992;369-374.
15. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
16. Matthews JN, Altman DF, Campbell MJ, Royston P Analysis of serial measurements in medical research. BMJ. 300:1990;230-235.
17. Haynes WG, Noon JP, Walker BR, Webb DJ Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 11:1993;1375-1380.
18. Olesen J Analgesic headache. BMJ. 310:1995;479-480.
19. Woolf CJ, Doubell TP The pathophysiology of chronic pain-increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol. 4:1994;525-534.
20. Coderre TJ, Katz J, Vaccarino AL, Melzack R Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
21. Mizukawa K, Vincent SR, McGeer PL, McGeer EG Distribution of reduced-nicotinamide-adenine-dinucleotide-phosphate diaphorase-positive cells and fibres in the cat central nervous system. J Comp Neurol. 279:1989;281-311.
22. Anderson CR NADPH diaphorase-positive neurons in the rat spinal cord include a subpopulation of autonomic preganglionic neurons. Neurosci Lett. 139:1992;280-284.
23. Morris R, Southam E, Gittins SRet al. The NO-cGMP pathway in neonatal rat dorsal horn. Eur J Neuroscience. 1:1994;876-879.
24. Roche AK, Cook M, Wilcox GL, Kajander KC A nitric oxide synthesis inhibitor (L-NAME) reduces licking behaviour and Fos-labelling in the spinal cord of rats during formalin-induced inflammation. Pain. 6:1996;331-341.
25. Southan GJ, Szabo C Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 4:1996;383-394.
26. Kindgen-Milles D, Arndt JO Nitric oxide as a chemical link in the generation of pain from veins in humans. Pain. 64:1996;139-142.
27. Holthusen H, Arndt JO Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J Physiol. 15:1995;253-258.
28. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J Nitric oxide synthase inhibition in migraine. Lancet. 349:1997;401-402.
29. Blitzer ML, Loh E, Roddy MAet al. Endothelium-drived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol. 28:1996;591-596.